Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-6834

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-6834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636296834)

This appears to be a product label for a medication called "Trileptal" in tablet form. It includes information about the manufacturer ("Nexgen Pharma, Inc."), the dosage (600mg), the quantity (#30), and the expiration date (MM/YY). The NDC number is also provided. The medication should be stored at room temperature and kept out of reach of children. There is also a reference to a packaging company.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This is a graph showing the exit rate over a trial period. On the x-axis, there are numbered days from day 2 to day 11. The y-axis shows exit rate from 0 to 1. There is a line for the placebo group. Additionally, there is a log-rank test with a p-value of 0.0001.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This is a statistical description of the seizure rate observed during a clinical trial. The log-rank test was performed and resulted in a p-value of 0.046 which suggests that there might be a significant difference between the two treatment groups - Oxcarbazepine and Placebo. The graph shows the number of days from the first dose to the first seizure for each treatment group.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This appears to be a survival analysis report for a treatment group that includes the calculation of an exit rate and the results of a log-rank test. The table shows the time to exit in days with markers for treatment group "HIGH" and "LOW".*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This is a survival analysis table presenting the "Time to exit" in days for a treatment group with two categories, "HIGH" and "LOW." The log-rank test was conducted with a p-value of 0.0001, and the exit rate at time zero is zero.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.